Next Article in Journal
Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease
Next Article in Special Issue
Septal Myectomy in Patients with Hypertrophic Cardiomyopathy and Nonclassical Anderson–Fabry Disease
Previous Article in Journal
In-Hospital versus Out-of-Hospital Pulmonary Embolism: Clinical Characteristics, Biochemical Markers and Echocardiographic Indices
Previous Article in Special Issue
Phospholamban p.Leu39* Cardiomyopathy Compared with Other Sarcomeric Cardiomyopathies: Age-Matched Patient Cohorts and Literature Review
 
 
Brief Report

Article Versions Notes

J. Cardiovasc. Dev. Dis. 2024, 11(4), 104; https://doi.org/10.3390/jcdd11040104
Action Date Notes Link
article xml file uploaded 29 March 2024 06:53 CET Original file -
article xml uploaded. 29 March 2024 06:53 CET Update https://www.mdpi.com/2308-3425/11/4/104/xml
article pdf uploaded. 29 March 2024 06:53 CET Version of Record https://www.mdpi.com/2308-3425/11/4/104/pdf
article supplementary file uploaded. 29 March 2024 06:53 CET - https://www.mdpi.com/2308-3425/11/4/104#supplementary
article html file updated 29 March 2024 06:54 CET Original file https://www.mdpi.com/2308-3425/11/4/104/html
Back to TopTop